Literature DB >> 30122537

RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.

Alexander J Meeske1, Luciano A Marraffini2.   

Abstract

All immune systems use precise target recognition to interrogate foreign invaders. During CRISPR-Cas immunity, prokaryotes capture short spacer sequences from infecting viruses and insert them into the CRISPR array. Transcription and processing of the CRISPR locus generate small RNAs containing the spacer and repeat sequences that guide Cas nucleases to cleave a complementary protospacer in the invading nucleic acids. In most CRISPR systems, sequences flanking the protospacer drastically affect cleavage. Here, we investigated the target requirements of the recently discovered RNA-targeting type VI-A CRISPR-Cas system in its natural host, Listeria seeligeri. We discovered that target RNAs with extended complementarity between the protospacer flanking sequence and the repeat sequence of the guide RNA are not cleaved by the type VI-A nuclease Cas13, neither in vivo nor in vitro. These findings establish fundamental rules for the design of Cas13-based technologies and provide a mechanism for preventing self-targeting in type VI-A systems.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas13; RNase; immunity

Mesh:

Substances:

Year:  2018        PMID: 30122537      PMCID: PMC7955661          DOI: 10.1016/j.molcel.2018.07.013

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

3.  Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition.

Authors:  Migle Kazlauskiene; Gintautas Tamulaitis; Georgij Kostiuk; Česlovas Venclovas; Virginijus Siksnys
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

4.  Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.

Authors:  Ole Niewoehner; Carmela Garcia-Doval; Jakob T Rostøl; Christian Berk; Frank Schwede; Laurent Bigler; Jonathan Hall; Luciano A Marraffini; Martin Jinek
Journal:  Nature       Date:  2017-07-19       Impact factor: 49.962

5.  Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.

Authors:  Wenyan Jiang; Poulami Samai; Luciano A Marraffini
Journal:  Cell       Date:  2016-02-04       Impact factor: 41.582

6.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

7.  Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.

Authors:  Alexandra East-Seletsky; Mitchell R O'Connell; Spencer C Knight; David Burstein; Jamie H D Cate; Robert Tjian; Jennifer A Doudna
Journal:  Nature       Date:  2016-09-26       Impact factor: 49.962

8.  C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Silvana Konermann; Julia Joung; Ian M Slaymaker; David B T Cox; Sergey Shmakov; Kira S Makarova; Ekaterina Semenova; Leonid Minakhin; Konstantin Severinov; Aviv Regev; Eric S Lander; Eugene V Koonin; Feng Zhang
Journal:  Science       Date:  2016-06-02       Impact factor: 47.728

9.  RNA targeting with CRISPR-Cas13.

Authors:  Omar O Abudayyeh; Jonathan S Gootenberg; Patrick Essletzbichler; Shuo Han; Julia Joung; Joseph J Belanto; Vanessa Verdine; David B T Cox; Max J Kellner; Aviv Regev; Eric S Lander; Daniel F Voytas; Alice Y Ting; Feng Zhang
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

10.  Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.

Authors:  Joshua R Elmore; Nolan F Sheppard; Nancy Ramia; Trace Deighan; Hong Li; Rebecca M Terns; Michael P Terns
Journal:  Genes Dev       Date:  2016-02-04       Impact factor: 11.361

View more
  19 in total

1.  Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.

Authors:  Beibei Wang; Tianlong Zhang; Jun Yin; You Yu; Wenhao Xu; Jianping Ding; Dinshaw J Patel; Hui Yang
Journal:  Mol Cell       Date:  2021-01-19       Impact factor: 17.970

2.  Target sequence requirements of a type III-B CRISPR-Cas immune system.

Authors:  Kaitlin Johnson; Brian A Learn; Michael A Estrella; Scott Bailey
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

3.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

Review 4.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

Review 5.  Three New Cs for CRISPR: Collateral, Communicate, Cooperate.

Authors:  Andrew Varble; Luciano A Marraffini
Journal:  Trends Genet       Date:  2019-04-27       Impact factor: 11.639

Review 6.  Alternative functions of CRISPR-Cas systems in the evolutionary arms race.

Authors:  Prarthana Mohanraju; Chinmoy Saha; Peter van Baarlen; Rogier Louwen; Raymond H J Staals; John van der Oost
Journal:  Nat Rev Microbiol       Date:  2022-01-06       Impact factor: 60.633

Review 7.  RNA-targeting CRISPR-Cas systems.

Authors:  Sam P B van Beljouw; Jasper Sanders; Alicia Rodríguez-Molina; Stan J J Brouns
Journal:  Nat Rev Microbiol       Date:  2022-09-28       Impact factor: 78.297

8.  A phage-encoded anti-CRISPR enables complete evasion of type VI-A CRISPR-Cas immunity.

Authors:  Alexander J Meeske; Ning Jia; Alice K Cassel; Albina Kozlova; Jingqiu Liao; Martin Wiedmann; Dinshaw J Patel; Luciano A Marraffini
Journal:  Science       Date:  2020-05-28       Impact factor: 47.728

9.  Cas13b-dependent and Cas13b-independent RNA knockdown of viral sequences in mosquito cells following guide RNA expression.

Authors:  Priscilla Ying Lei Tng; Leonela Carabajal Paladino; Sebald Alexander Nkosana Verkuijl; Jessica Purcell; Andres Merits; Philip Thomas Leftwich; Rennos Fragkoudis; Rob Noad; Luke Alphey
Journal:  Commun Biol       Date:  2020-07-31

Review 10.  Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.

Authors:  Vanja Perčulija; Jinying Lin; Bo Zhang; Songying Ouyang
Journal:  Adv Sci (Weinh)       Date:  2021-05-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.